(Health-NewsWire.Net, July 25, 2017 ) Publisher's Medical Devices sector report, "Dry Powder Inhaler Devices - Medical Devices Pipeline Assessment, 2017" provides an overview of Dry Powder Inhaler Devices currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Dry Powder Inhaler Devices pipeline products.
For more information about this report: http://www.reportsweb.com/dry-powder-inhaler-devices-medical-devices-pipeline-assessment-2017
This report is prepared using data sourced from in-house databases, secondary and primary research by Publisher's team of industry experts.
-Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Dry Powder Inhaler Devices under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Dry Powder Inhaler Devices and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001866661/sample
Reasons to buy
The report enables you to - - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of Dry Powder Inhaler Devices under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the product's current stage of development, territory and estimated launch date Companies Mentioned: Acorda Therapeutics Inc Adamis Pharmaceuticals Corp Advent Pharmaceuticals Pty Ltd Aespira Ltd. AKELA Pharma Inc. Bayer HealthCare AG Bespak Europe Ltd Boehringer Ingelheim GmbH Circassia Pharmaceuticals Plc GlaxoSmithKline Plc MannKind Corp Monash University Nanotherapeutics Inc Nektar Therapeutics Novartis AG OPKO Health Inc Pharmaxis Ltd Respira Therapeutics Inc Sandoz International GmbH Sheffield Hallam University Shin Nippon Biomedical Laboratories Ltd Sun Pharma Advanced Research Company Ltd Teva Pharmaceutical Industries Ltd University of Kansas University of Texas Medical Branch at Galveston Vectura Group Plc Verona Pharma Plc Virginia Commonwealth University Inquire for Report at http://www.reportsweb.com/inquiry&RW0001866661/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|